SCHEMBL2013911

SCHEMBL2013911

CN(C(=O)c1cn(C)c2ncccc12)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.59
HCRTR2 O43614 2/20 0.59
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
CNR1 P21554 2/20 0.40
CNR2 P34972 2/20 0.40
PADI4 Q9UM07 3/20 0.39
PKM P14618 1/20 0.38
OPRM1 P35372 1/20 0.36
KDM4E B2RXH2 1/20 0.36
KDM6B O15054 1/20 0.36
KDM5A P29375 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
HRH3 Q9Y5N1 2/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2012147 0.87 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9AHDAC1
SCHEMBL2051271 0.87 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9AHDAC1
SCHEMBL2012487 0.87 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2015191 0.86 HCRTR1 (0.62) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2013351 0.86 HCRTR1 (0.58) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2016933 0.86 HCRTR1 (0.60) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2054308 0.85 HCRTR1 (0.60) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2011844 0.85 HCRTR1 (0.60) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2011800 0.85 HCRTR1 (0.60) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL6919977 0.84 HCRTR1 (0.58) HCRTR1HCRTR2NPC1RAB9APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed